Navigation Links
PNNL chemist earns NIH New Innovator Award
Date:9/23/2009

RICHLAND, Wash. -- An analytical chemist at the Department of Energy's Pacific Northwest National Laboratory has been recognized with a National Institutes of Health Director's New Innovator Award. The award will support Wei-Jun Qian's drive to make new research and clinical diagnostic tools that are dramatically more sensitive, reliable and faster than current technologies.

The award, which comes with a $1.5 million, five-year grant, recognizes researchers early in their careers. Qian has been studying proteomics -- or the proteins that make organisms work -- at PNNL only since 2002 but has already published more than 60 scientific papers. NIH selected projects that show creativity and are considered high-risk ventures but with the potential to make a significant impact.

"This is great news for Wei-Jun and highlights the significant instrument development capabilities at PNNL," said Doug Ray, director of Fundamental & Computational Sciences at PNNL. "Not many DOE researchers earn such a prestigious NIH award. For his first grant, this is a major achievement."

Qian earned this honor for his proposal to increase the ability of research tools to detect diagnostic molecules in blood or tissue enough so they can replace conventional tools. When patients enter clinics now, they donate up to an ounce or two of blood so that multiple tests can be done. Each test -- for cholesterol, liver health, or cancer markers -- is generally performed seperately. A slate of 20 tests is far more labor and time intensive than just one. Qian would like to develop a single test for 20 diseases.

Research laboratories such as those found in EMSL, DOE's molecular sciences laboratory on the PNNL campus, have instruments called mass spectrometers that can identify hundreds of proteins and other molecules floating in a drop of that ounce of blood. Although much faster, the instruments aren't sensitive and accurate enough to compare with the clinical lab tests done one at a time.

"We are aiming to increase the sensitivity of our instrument so that we can detect proteins whose concentrations in blood are very low, and at the same time accurately measure their concentration for hundreds of different proteins -- perhaps up to a thousand," said Qian. "We hope this platform will lead to a paradigm change in how clinics do their testing."

Qian's plan will pull together tools that have been in development by the proteomics team at PNNL and EMSL for several years, but it will also require developing new technologies. The complete instrument identifies molecules in a sample such as blood by first separating them by size and shape and then measuring their mass as they flow past a detector.

Because different molecules can have the same mass, the technique breaks down molecules and identifies smaller pieces, which computer programs then recognize as belonging to certain molecules. Different molecules of the same mass will break into different pieces, much as the pieces of a 30-pound bike will be different from those of a 30-pound coffee table.

To improve the instruments' ability to detect rare molecules, Qian and his group have to increase the percentage of molecules in the sample that make it into the instrument at the beginning, as well as how many can be identified individually near the end. To improve the identification of individual molecules, Qian proposed that breaking down fragments into even more pieces will increase the resolving power of the detector.

"Eventually, the instrument will find a piece that is so unique we know which molecule it had to come from," Qian said.

Although such an instrument might replace current clinical tests someday, it will be equally valuable in the research laboratory, enabling scientists to screen many samples much faster than they are capable of now. This will cut down the time to find biomarkers -- proteins in the blood that indicate disease. For example, breast cancer researchers have identified almost 1000 proteins that show up or disappear, depending on the protein, when cancer is present. This technology could speed up the experiments needed to determine which of those are important for diagnosing illness.


'/>"/>

Contact: Mary Beckman
mary.beckman@pnl.gov
509-375-3688
DOE/Pacific Northwest National Laboratory
Source:Eurekalert  

Related biology news :

1. Clemson chemists discover new way antioxidants fight debilitating diseases
2. Computational actinide chemistry: Are we there yet?
3. Chemists get grip on slippery lipids
4. American Chemical Society calls green chemistry bill a smart step
5. Using green chemistry to deliver cutting-edge drugs
6. Good earth: Brown chemists show origin of soil-scented geosmin
7. Penn biochemist receives NIH New Innovators Award
8. Chemistry turns killer gas into potential cure
9. K-State chemistry professor to receive Masao Horiba award
10. Yale chemist receives NIH Young Investigator Award for antibody targeting
11. Biogeochemistry -- A window into the Earths ecological health
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
PNNL chemist earns NIH New Innovator Award
(Date:6/23/2017)... and ITHACA, N.Y. , June 23, ... University, a leader in dairy research, today announced a ... to help reduce the chances that the global milk ... of this dairy project, Cornell University has become the ... the Food Supply Chain, a food safety initiative that ...
(Date:5/23/2017)... May 23, 2017  Hunova, the first robotic gym for the rehabilitation ... officially launched in Genoa, Italy . The first 30 ... and the USA . The technology was developed and ... by the IIT spin-off Movendo Technology thanks to a 10 million euro ... Release, please click: ...
(Date:5/16/2017)... , May 16, 2017   Bridge ... health organizations, and MD EMR Systems , ... development partner for GE, have established a partnership ... Portal product and the GE Centricityâ„¢ products, including ... EMR. These new integrations will ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... 2017 , ... At its national board meeting in North ... the co-founder, CEO and chief research scientist of Minnesota-based Advanced Space Technology and ... ARCS Alumni Hall of Fame . ASTER Labs is a technology development ...
(Date:10/11/2017)... CA, USA (PRWEB) , ... October 11, 2017 , ... ... to take place on 7th and 8th June 2018 in San Francisco, CA. The ... influencers as well as several distinguished CEOs, board directors and government officials from around ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofilerâ„¢ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
Breaking Biology Technology: